{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T18:57:00Z","timestamp":1788893820975,"version":"build-2803163510"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T00:00:00Z","timestamp":1623888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T00:00:00Z","timestamp":1623888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s00105-021-04829-x","type":"journal-article","created":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T13:04:06Z","timestamp":1623935046000},"page":"619-632","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Management von malignen Adnextumoren der Haut","Management of malignant adnexal neoplasms of the skin"],"prefix":"10.1007","volume":"72","author":[{"given":"Pia","family":"Nagel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Utikal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,17]]},"reference":[{"key":"4829_CR1","volume-title":"WHO classification of skin tumours","author":"Weltgesundheitsorganisation","year":"2018","unstructured":"Weltgesundheitsorganisation (2018) WHO classification of skin tumours. International Agency for Research on Cancer, Lyon"},{"key":"4829_CR2","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/jso.23331","volume":"107","author":"H Stam","year":"2013","unstructured":"Stam\u00a0H, Lohuis\u00a0PJ, Zupan-Kajcovski\u00a0B et al (2013) Increasing incidence and survival of a\u00a0rare skin cancer in the Netherlands. A population-based study of 2,220\u00a0cases of skin adnexal carcinoma. J\u00a0Surg Oncol 107:822\u2013827","journal-title":"J Surg Oncol"},{"key":"4829_CR3","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fmed.2019.00160","volume":"6","author":"K Tanese","year":"2019","unstructured":"Tanese\u00a0K, Nakamura\u00a0Y, Hirai\u00a0I et al (2019) Updates on the systemic treatment of advanced non-melanoma skin cancer. Front Med 6:160","journal-title":"Front Med"},{"key":"4829_CR4","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.amjoto.2018.09.011","volume":"40","author":"DB Jandali","year":"2019","unstructured":"Jandali\u00a0DB, Ganti\u00a0A, Al-Khudari\u00a0S et al (2019) Prognostic factors and survival outcomes for head and neck cutaneous adnexal cancers. Am J Otolaryngol 40:110\u2013114","journal-title":"Am J Otolaryngol"},{"key":"4829_CR5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13256-017-1212-8","volume":"11","author":"O Waqas","year":"2017","unstructured":"Waqas\u00a0O, Faisal\u00a0M, Haider\u00a0I et\u00a0al (2017) Retrospective study of rare cutaneous malignant adnexal tumors of the head and neck in a\u00a0tertiary care cancer hospital: a\u00a0case series. J\u00a0Med Case Rep 11:67","journal-title":"J Med Case Rep"},{"key":"4829_CR6","first-page":"1035","volume":"29","author":"M Abbate","year":"2003","unstructured":"Abbate\u00a0M, Zeitouni\u00a0NC, Seyler\u00a0M et\u00a0al (2003) Clinical course, risk factors, and treatment of microcystic adnexal carcinoma: a\u00a0short series report. Dermatol Surg 29:1035\u20131038","journal-title":"Dermatol Surg"},{"key":"4829_CR7","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1001\/archdermatol.2010.105","volume":"146","author":"PW Blake","year":"2010","unstructured":"Blake\u00a0PW, Bradford\u00a0PT, Devesa\u00a0SS et al (2010) Cutaneous appendageal carcinoma incidence and survival patterns in the United States: a\u00a0population-based study. Arch Dermatol 146:625\u2013632","journal-title":"Arch Dermatol"},{"key":"4829_CR8","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/bjd.17321","volume":"180","author":"V De Giorgi","year":"2019","unstructured":"De Giorgi\u00a0V, Salvati\u00a0L, Barchielli\u00a0A et al (2019) The burden of cutaneous adnexal carcinomas and the risk of associated squamous cell carcinoma: a\u00a0population-based study. Br J Dermatol 180:565\u2013573","journal-title":"Br J Dermatol"},{"key":"4829_CR9","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1067\/mjd.2003.97","volume":"48","author":"CA Harwood","year":"2003","unstructured":"Harwood\u00a0CA, Mcgregor\u00a0JM, Swale\u00a0VJ et\u00a0al (2003) High frequency and diversity of cutaneous appendageal tumors in organ transplant recipients. J\u00a0Am Acad Dermatol 48:401\u2013408","journal-title":"J Am Acad Dermatol"},{"key":"4829_CR10","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/QAD.0b013e3283213046","volume":"23","author":"E Lanoy","year":"2009","unstructured":"Lanoy\u00a0E, Dores\u00a0GM, Madeleine\u00a0MM et\u00a0al (2009) Epidemiology of nonkeratinocytic skin cancers among persons with AIDS in the United States. AIDS 23:385\u2013393","journal-title":"AIDS"},{"key":"4829_CR11","first-page":"157","volume":"77","author":"JC Fueston","year":"2006","unstructured":"Fueston\u00a0JC, Gloster\u00a0HM, Mutasim\u00a0DF (2006) Primary cutaneous adenoid cystic carcinoma: a\u00a0case report and literature review. Cutis 77:157\u2013160","journal-title":"Cutis"},{"key":"4829_CR12","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/DSS.0000000000001483","volume":"44","author":"K Rismiller","year":"2018","unstructured":"Rismiller\u00a0K, Knackstedt\u00a0TJ (2018) Aggressive digital papillary adenocarcinoma: population-based analysis of incidence, demographics, treatment, and outcomes. Dermatol Surg 44:911\u2013917","journal-title":"Dermatol Surg"},{"key":"4829_CR13","doi-asserted-by":"crossref","first-page":"e699","DOI":"10.1016\/S1470-2045(19)30673-4","volume":"20","author":"JL Owen","year":"2019","unstructured":"Owen\u00a0JL, Kibbi\u00a0N, Worley\u00a0B et al (2019) Sebaceous carcinoma: evidence-based clinical practice guidelines. Lancet Oncol 20:e699\u2013e714","journal-title":"Lancet Oncol"},{"issue":"9","key":"4829_CR14","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1001\/jamadermatol.2019.1251","volume":"155","author":"B Worley","year":"2019","unstructured":"Worley B, Owen JL, Barker CA et al (2019) Evidence-based clinical practice guidelines for microcystic adnexal carcinoma: informed by a\u00a0systematic review. JAMA Dermatol 155(9):1059\u20131068. https:\/\/doi.org\/10.1001\/jamadermatol.2019.1251","journal-title":"JAMA Dermatol"},{"key":"4829_CR15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/jcp.2006.040337","volume":"60","author":"KO Alsaad","year":"2007","unstructured":"Alsaad\u00a0KO, Obaidat\u00a0NA, Ghazarian\u00a0D (2007) Skin adnexal neoplasms-\u2014part 1: an approach to tumours of the pilosebaceous unit. J\u00a0Clin Pathol 60:129\u2013144","journal-title":"J Clin Pathol"},{"key":"4829_CR16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/jcp.2006.041608","volume":"60","author":"NA Obaidat","year":"2007","unstructured":"Obaidat\u00a0NA, Alsaad\u00a0KO, Ghazarian\u00a0D (2007) Skin adnexal neoplasms\u2014part 2: an approach to tumours of cutaneous sweat glands. J\u00a0Clin Pathol 60:145\u2013159","journal-title":"J Clin Pathol"},{"key":"4829_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-020-02143-5","volume-title":"Surgical management and lymph-node biopsy of rare malignant cutaneous adnexal carcinomas: a\u00a0population-based analysis of 7591\u00a0patients. Arch Dermatol Res","author":"A Goyal","year":"2020","unstructured":"Goyal A, Marghitu T, Goyal N et al (2020) Surgical management and lymph-node biopsy of rare malignant cutaneous adnexal carcinomas: a\u00a0population-based analysis of 7591\u00a0patients. Arch Dermatol Res. https:\/\/doi.org\/10.1007\/s00403-020-02143-5"},{"key":"4829_CR18","volume-title":"TNM \u2013 Klassifikation maligner Tumoren","author":"C Wittekind","year":"2020","unstructured":"Wittekind\u00a0C (2020) TNM \u2013 Klassifikation maligner Tumoren. Wiley-VCH, Weinheim"},{"key":"4829_CR19","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1001\/archdermatol.2011.229","volume":"147","author":"SR Martinez","year":"2011","unstructured":"Martinez\u00a0SR, Barr\u00a0KL, Canter\u00a0RJ (2011) Rare tumors through the looking glass: an examination of malignant cutaneous adnexal tumors. Arch Dermatol 147:1058\u20131062","journal-title":"Arch Dermatol"},{"key":"4829_CR20","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ad.2017.04.005","volume":"109","author":"C Bern\u00e1rdez","year":"2018","unstructured":"Bern\u00e1rdez\u00a0C, Requena\u00a0L (2018) Treatment of malignant cutaneous Adnexal neoplasms. Actas Dermosifiliogr 109:6\u201323","journal-title":"Actas Dermosifiliogr"},{"key":"4829_CR21","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1365-2133.2011.10486.x","volume":"165","author":"E Belin","year":"2011","unstructured":"Belin\u00a0E, Ezzedine\u00a0K, Stanislas\u00a0S et\u00a0al (2011) Factors in the surgical management of primary eccrine porocarcinoma: prognostic histological factors can guide the surgical procedure. Br J Dermatol 165:985\u2013989","journal-title":"Br J Dermatol"},{"key":"4829_CR22","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00000372-200110000-00002","volume":"23","author":"D Hardisson","year":"2001","unstructured":"Hardisson\u00a0D, Linares\u00a0MD, Cuevas-Santos\u00a0J et al (2001) Pilomatrix carcinoma: a\u00a0clinicopathologic study of six cases and review of the literature. Am J Dermatopathol 23:394\u2013401","journal-title":"Am J Dermatopathol"},{"key":"4829_CR23","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.0303-6987.2005.00267.x","volume":"32","author":"AJ Lazar","year":"2005","unstructured":"Lazar\u00a0AJ, Calonje\u00a0E, Grayson\u00a0W et al (2005) Pilomatrix carcinomas contain mutations in CTNNB1, the gene encoding beta-catenin. J\u00a0Cutan Pathol 32:148\u2013157","journal-title":"J Cutan Pathol"},{"key":"4829_CR24","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/j.suronc.2010.09.005","volume":"20","author":"ID Kyriazanos","year":"2011","unstructured":"Kyriazanos\u00a0ID, Stamos\u00a0NP, Miliadis\u00a0L et al (2011) Extra-mammary Paget\u2019s disease of the perianal region: a\u00a0review of the literature emphasizing the operative management technique. Surg Oncol 20:e61\u2013e71","journal-title":"Surg Oncol"},{"key":"4829_CR25","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.urology.2019.03.006","volume":"128","author":"PH Chung","year":"2019","unstructured":"Chung\u00a0PH, Leong\u00a0JY, Voelzke\u00a0BB (2019) Surgical experience with genital and perineal extramammary Paget\u2019s disease. Urology 128:90\u201395","journal-title":"Urology"},{"key":"4829_CR26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11864-018-0545-x","volume":"19","author":"U Wollina","year":"2018","unstructured":"Wollina\u00a0U, Goldman\u00a0A, Bieneck\u00a0A et\u00a0al (2018) Surgical treatment for extramammary Paget\u2019s disease. Curr Treat Options Oncol 19:27","journal-title":"Curr Treat Options Oncol"},{"issue":"4","key":"4829_CR27","first-page":"13030","volume":"26","author":"Y Dokic","year":"2020","unstructured":"Dokic Y, Nguyen QL, Orengo I (2020) Mohs micrographic surgery: a\u00a0treatment method for many non-melanocytic skin cancers. Dermatol Online\u00a0J 26(4):13030\/qt8zr4f9n4","journal-title":"Online"},{"key":"4829_CR28","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/COC.0000000000000178","volume":"40","author":"LS Wang","year":"2017","unstructured":"Wang\u00a0LS, Handorf\u00a0EA, Wu\u00a0H et al (2017) Surgery and adjuvant radiation for high-risk skin Adnexal carcinoma of the head and neck. Am J Clin Oncol 40:429\u2013432","journal-title":"Am J Clin Oncol"},{"issue":"6","key":"4829_CR29","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1159\/000506832","volume":"236","author":"I Snast","year":"2020","unstructured":"Snast I, Sharon E, Kaftory R et al (2020) Nonsurgical treatments for extramammary Paget disease: a systematic review and meta-analysis. Dermatology 236(6):493\u2013499. https:\/\/doi.org\/10.1159\/000506832","journal-title":"Dermatology"},{"key":"4829_CR30","doi-asserted-by":"crossref","first-page":"e12830","DOI":"10.1111\/dth.12830","volume":"32","author":"T Nagasawa","year":"2019","unstructured":"Nagasawa\u00a0T, Hirata\u00a0A, Niiyama\u00a0S et\u00a0al (2019) Successful treatment of porocarcinoma with maxacalcitol and imiquimod. Dermatol Ther 32:e12830","journal-title":"Dermatol Ther"},{"key":"4829_CR31","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/00042728-200508000-00016","volume":"31","author":"JH Jo","year":"2005","unstructured":"Jo\u00a0JH, Ko\u00a0HC, Jang\u00a0HS et\u00a0al (2005) Infiltrative trichilemmal carcinoma treated with 5\u202f% imiquimod cream. Dermatol Surg 31:973\u2013976","journal-title":"Dermatol Surg"},{"key":"4829_CR32","doi-asserted-by":"crossref","first-page":"6485","DOI":"10.21873\/anticanres.14670","volume":"40","author":"L Borgognoni","year":"2020","unstructured":"Borgognoni\u00a0L, Pescitelli\u00a0L, Gerlini\u00a0G et al (2020) Efficacy of electrochemotherapy in the treatment of cutaneous melanoma metastases and rare non-melanoma skin cancer. Anticancer Res 40:6485\u20136492","journal-title":"Anticancer Res"},{"key":"4829_CR33","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.2217\/fon.14.141","volume":"10","author":"L Borgognoni","year":"2014","unstructured":"Borgognoni\u00a0L, Pescitelli\u00a0L, Urso\u00a0C et\u00a0al (2014) A rare case of anal porocarcinoma treated by electrochemotherapy. Future Oncol 10:2429\u20132434","journal-title":"Future Oncol"},{"key":"4829_CR34","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1515\/raon-2016-0039","volume":"50","author":"S Ribero","year":"2016","unstructured":"Ribero\u00a0S, Baduel\u00a0ES, Brizio\u00a0M et\u00a0al (2016) Metastatic sebaceous cell carcinoma, review of the literature and use of electrochemotherapy as possible new treatment modality. Radiol Oncol 50:308\u2013312","journal-title":"Radiol Oncol"},{"key":"4829_CR35","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1365-2230.2009.03654.x","volume":"35","author":"A Wakabayashi","year":"2010","unstructured":"Wakabayashi\u00a0A, Tanese\u00a0K, Yamamoto\u00a0K et\u00a0al (2010) Extraocular sebaceous carcinoma expressing oestrogen receptor alpha and human epidermal growth factor receptor 2. Clin Exp Dermatol 35:546\u2013548","journal-title":"Clin Exp Dermatol"},{"key":"4829_CR36","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1468-3083.2009.03407.x","volume":"24","author":"K Tanese","year":"2010","unstructured":"Tanese\u00a0K, Wakabayashi\u00a0A, Suzuki\u00a0T et al (2010) Immunoexpression of human epidermal growth factor receptor\u20112 in apocrine carcinoma arising in naevus sebaceous, case report. J\u00a0Eur Acad Dermatol Venereol 24:360\u2013362","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4829_CR37","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/1346-8138.13080","volume":"42","author":"Y Ohi","year":"2015","unstructured":"Ohi\u00a0Y, Kosuge\u00a0H, Tanese\u00a0K (2015) Case of syringomatous carcinoma: Positive immunohistochemical staining of c\u2011KIT and phosphorylated-extracellular signal-regulated kinase 1\/2. J\u00a0Dermatol 42:1191\u20131192","journal-title":"J Dermatol"},{"key":"4829_CR38","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/modpathol.3800007","volume":"17","author":"KM Hiatt","year":"2004","unstructured":"Hiatt\u00a0KM, Pillow\u00a0JL, Smoller\u00a0BR (2004) Her\u20112 expression in cutaneous eccrine and apocrine neoplasms. Mod Pathol 17:28\u201332","journal-title":"Mod Pathol"},{"key":"4829_CR39","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00262-019-02334-8","volume":"68","author":"L Duverger","year":"2019","unstructured":"Duverger\u00a0L, Osio\u00a0A, Cribier\u00a0B et al (2019) Heterogeneity of PD-L1 expression and CD8 tumor-infiltrating lymphocytes among subtypes of cutaneous adnexal carcinomas. Cancer Immunol Immunother 68:951\u2013960","journal-title":"Cancer Immunol Immunother"},{"key":"4829_CR40","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3332\/ecancer.2015.517","volume":"9","author":"A Soni","year":"2015","unstructured":"Soni\u00a0A, Bansal\u00a0N, Kaushal\u00a0V et\u00a0al (2015) Current management approach to hidradenocarcinoma: a\u00a0comprehensive review of the literature. Ecancermedicalscience 9:517","journal-title":"Ecancermedicalscience"},{"key":"4829_CR41","first-page":"e7091","volume":"12","author":"EP Johnson","year":"2020","unstructured":"Johnson\u00a0EP, Keyes\u00a0J, Zayat\u00a0V et\u00a0al (2020) Malignant hidradenocarcinoma of the Axilla. Cureus 12:e7091","journal-title":"Cureus"},{"key":"4829_CR42","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1097\/00000478-200106000-00002","volume":"25","author":"A Robson","year":"2001","unstructured":"Robson\u00a0A, Greene\u00a0J, Ansari\u00a0N et\u00a0al (2001) Eccrine porocarcinoma (malignant eccrine poroma): a\u00a0clinicopathologic study of 69\u00a0cases. Am J Surg Pathol 25:710\u2013720","journal-title":"Am J Surg Pathol"},{"key":"4829_CR43","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1097\/DSS.0000000000001566","volume":"44","author":"A Nazemi","year":"2018","unstructured":"Nazemi\u00a0A, Higgins\u00a0S, Swift\u00a0R et\u00a0al (2018) Eccrine porocarcinoma: new insights and a\u00a0systematic review of the literature. Dermatol Surg 44:1247\u20131261","journal-title":"Dermatol Surg"},{"key":"4829_CR44","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaad.2014.02.042","volume":"71","author":"JL Herrmann","year":"2014","unstructured":"Herrmann\u00a0JL, Allan\u00a0A, Trapp\u00a0KM et\u00a0al (2014) Pilomatrix carcinoma: 13 new cases and review of the literature with emphasis on predictors of metastasis. J\u00a0Am Acad Dermatol 71:38\u201343.e32","journal-title":"J Am Acad Dermatol"},{"key":"4829_CR45","first-page":"400","volume":"18","author":"U Leiter","year":"2020","unstructured":"Leiter\u00a0U, Heppt\u00a0MV, Steeb\u00a0T et al (2020) S3-Leitlinie \u201eAktinische Keratose und Plattenepithelkarzinom der Haut\u201c \u2013 Kurzfassung, Teil 2: Epidemiologie, chirurgische und systemische Therapie des Plattenepithelkarzinoms, Nachsorge, Pr\u00e4vention und Berufskrankheit. J\u00a0Dtsch Dermatol Ges 18:400\u2013413","journal-title":"J Dtsch Dermatol Ges"},{"key":"4829_CR46","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1001\/archderm.1983.01650260012008","volume":"119","author":"AH Mehregan","year":"1983","unstructured":"Mehregan\u00a0AH, Hashimoto\u00a0K, Rahbari\u00a0H (1983) Eccrine adenocarcinoma. A clinicopathologic study of 35\u00a0cases. Arch Dermatol 119:104\u2013114","journal-title":"Arch Dermatol"},{"key":"4829_CR47","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1477-7819-9-32","volume":"9","author":"U Marone","year":"2011","unstructured":"Marone\u00a0U, Carac\u00f2\u00a0C, Anniciello\u00a0AM et\u00a0al (2011) Metastatic eccrine porocarcinoma: report of a\u00a0case and review of the literature. World J Surg Oncol 9:32","journal-title":"World J Surg Oncol"},{"key":"4829_CR48","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1046\/j.1365-2133.2001.04475.x","volume":"145","author":"M Kurokawa","year":"2001","unstructured":"Kurokawa\u00a0M, Amano\u00a0M, Miyaguni\u00a0H et\u00a0al (2001) Eccrine poromas in a\u00a0patient with mycosis fungoides treated with electron beam therapy. Br J Dermatol 145:830\u2013833","journal-title":"Br J Dermatol"},{"key":"4829_CR49","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1365-2133.1982.tb00527.x","volume":"107","author":"M Shaw","year":"1982","unstructured":"Shaw\u00a0M, Mckee\u00a0PH, Lowe\u00a0D et al (1982) Malignant eccrine poroma: a\u00a0study of twenty-seven cases. Br J Dermatol 107:675\u2013680","journal-title":"Br J Dermatol"},{"key":"4829_CR50","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/DSS.0000000000000286","volume":"41","author":"SS Song","year":"2015","unstructured":"Song\u00a0SS, Wu\u00a0LW, Hamman\u00a0MS et\u00a0al (2015) Mohs micrographic surgery for eccrine porocarcinoma: an update and review of the literature. Dermatol Surg 41:301\u2013306","journal-title":"Dermatol Surg"},{"key":"4829_CR51","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/0190-9622(92)70187-K","volume":"27","author":"SN Snow","year":"1992","unstructured":"Snow\u00a0SN, Reizner\u00a0GT (1992) Eccrine porocarcinoma of the face. J\u00a0Am Acad Dermatol 27:306\u2013311","journal-title":"J Am Acad Dermatol"},{"key":"4829_CR52","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.hoc.2018.09.002","volume":"33","author":"CS Ahn","year":"2019","unstructured":"Ahn\u00a0CS, Sang\u00fceza\u00a0OP (2019) Malignant sweat gland tumors. Hematol Oncol Clin North Am 33:53\u201371","journal-title":"Hematol Oncol Clin North Am"},{"key":"4829_CR53","first-page":"43","volume":"93","author":"A Nguyen","year":"2014","unstructured":"Nguyen\u00a0A, Nguyen\u00a0AV (2014) Eccrine porocarcinoma: a\u00a0report of 2\u00a0cases and review of the literature. Cutis 93:43\u201346","journal-title":"Cutis"},{"key":"4829_CR54","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2340\/00015555-3173","volume":"99","author":"K Tsunoda","year":"2019","unstructured":"Tsunoda\u00a0K, Onishi\u00a0M, Maeda\u00a0F et\u00a0al (2019) Evaluation of sentinel lymph node biopsy for eccrine porocarcinoma. Acta Derm Venereol 99:691\u2013692","journal-title":"Acta Derm Venereol"},{"key":"4829_CR55","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.amsu.2017.06.027","volume":"20","author":"AM Salih","year":"2017","unstructured":"Salih\u00a0AM, Kakamad\u00a0FH, Baba\u00a0HO et al (2017) Porocarcinoma; presentation and management, a\u00a0meta-analysis of 453\u00a0cases. Ann Med Surg 20:74\u201379","journal-title":"Ann Med Surg"},{"key":"4829_CR56","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1002\/cncr.11328","volume":"97","author":"PN Bogner","year":"2003","unstructured":"Bogner\u00a0PN, Fullen\u00a0DR, Lowe\u00a0L et\u00a0al (2003) Lymphatic mapping and sentinel lymph node biopsy in the detection of early metastasis from sweat gland carcinoma. Cancer 97:2285\u20132289","journal-title":"Cancer"},{"key":"4829_CR57","doi-asserted-by":"crossref","first-page":"179","DOI":"10.12659\/AJCR.913440","volume":"20","author":"M Khaja","year":"2019","unstructured":"Khaja\u00a0M, Ashraf\u00a0U, Mehershahi\u00a0S et\u00a0al (2019) Recurrent metastatic eccrine porocarcinoma: a case report and review of the literature. Am J Case Rep 20:179\u2013183","journal-title":"Am J Case Rep"},{"key":"4829_CR58","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejca.2017.11.009","volume":"90","author":"C Godillot","year":"2018","unstructured":"Godillot\u00a0C, Boulinguez\u00a0S, Riffaud\u00a0L et\u00a0al (2018) Complete response of a\u00a0metastatic porocarcinoma treated with paclitaxel, cetuximab and radiotherapy. Eur J Cancer 90:142\u2013145","journal-title":"Eur J Cancer"},{"issue":"9","key":"4829_CR59","doi-asserted-by":"publisher","first-page":"e228917","DOI":"10.1136\/bcr-2018-228917","volume":"12","author":"KA Lee","year":"2019","unstructured":"Lee KA, Cioni M, Robson A et\u00a0al (2019) Metastatic porocarcinoma achieving complete radiological and clinical response with pembrolizumab. BMJ Case Rep 12(9):e228917. https:\/\/doi.org\/10.1136\/bcr-2018-228917","journal-title":"BMJ Case Rep"},{"key":"4829_CR60","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1136\/bjophthalmol-2018-312635","volume":"103","author":"HS Sa","year":"2019","unstructured":"Sa\u00a0HS, Rubin\u00a0ML, Xu\u00a0S et\u00a0al (2019) Prognostic factors for local recurrence, metastasis and survival for sebaceous carcinoma of the eyelid: observations in 100\u00a0patients. Br J Ophthalmol 103:980\u2013984","journal-title":"Br J Ophthalmol"},{"key":"4829_CR61","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/gim.2014.19","volume":"16","author":"ME Roberts","year":"2014","unstructured":"Roberts\u00a0ME, Riegert-Johnson\u00a0DL, Thomas\u00a0BC et al (2014) A clinical scoring system to identify patients with sebaceous neoplasms at risk for the Muir-Torre variant of Lynch syndrome. Genet Med 16:711\u2013716","journal-title":"Genet Med"},{"key":"4829_CR62","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00403-019-01971-4","volume":"312","author":"N Kibbi","year":"2020","unstructured":"Kibbi\u00a0N, Worley\u00a0B, Owen\u00a0JL et\u00a0al (2020) Sebaceous carcinoma: controversies and their evidence for clinical practice. Arch Dermatol Res 312:25\u201331","journal-title":"Arch Dermatol Res"},{"key":"4829_CR63","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1046\/j.1524-4725.2000.00005.x","volume":"26","author":"P Carroll","year":"2000","unstructured":"Carroll\u00a0P, Goldstein\u00a0GD, Brown\u00a0CW Jr. (2000) Metastatic microcystic adnexal carcinoma in an immunocompromised patient. Dermatol Surg 26:531\u2013534","journal-title":"Dermatol Surg"},{"key":"4829_CR64","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-49544-5_10","volume-title":"Braun-Falco\u2019s Dermatologie, Venerologie und Allergologie. Springer Reference Medizin","author":"A R\u00fctten","year":"2018","unstructured":"R\u00fctten\u00a0A (2018) Tumoren der Hautadnexe. In: Plewig\u00a0G, Ruzicka\u00a0T, Kaufmann\u00a0R, Hertl\u00a0M (Hrsg) Braun-Falco\u2019s Dermatologie, Venerologie und Allergologie. Springer Reference Medizin. Springer, Berlin, Heidelberg https:\/\/doi.org\/10.1007\/978-3-662-49544-5_10"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-021-04829-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-021-04829-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-021-04829-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T14:07:26Z","timestamp":1624889246000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-021-04829-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,17]]},"references-count":64,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["4829"],"URL":"https:\/\/doi.org\/10.1007\/s00105-021-04829-x","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,17]]},"assertion":[{"value":"21 April 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>J.S.\u00a0Utikal<\/b>: A.\u00a0Finanzielle Interessen: Forschungsf\u00f6rderung zur pers\u00f6nlichen Verf\u00fcgung: DFG, Dt. Krebshilfe, Bundesministerium f\u00fcr Forschung (BMBF), Deutsches Zentrum f\u00fcr Herz-Kreislauf-Forschung (DZHK), Baden W\u00fcrttemberg-Stiftung, Heidelberg Karlsruhe Research Partnership (HEiKA), ZIM-Kooperationsprojekte, Reliable Cancer Therapies, Bundesministerium f\u00fcr Forschung.\u00a0\u2013 Referentenhonorar oder Kostenerstattung als passiver Teilnehmer, bezahlter Berater\/interner Schulungsreferent\/Gehaltsempf\u00e4nger o.\u202f\u00c4.: Amgen, Bristol-Myers Squibb, GSK, LEO Pharma, Merck Sharp and Dohme, Novartis, Pierre Fabre, Roche, Sanofi.\u00a0\u2013 Aktien: Biontech, Pfizer, Moderna, Sanofi, GSK.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Leiter der Hautkrebseinheit, DKFZ, Universit\u00e4tsmedizin Mannheim | Mitgliedschaften: DDG, ADO, ADF. <b>P.\u00a0Nagel<\/b>: A.\u00a0Finanzielle Interessen: P.\u00a0Nagel gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Doktorandin, Klinische Kooperationseinheit f\u00fcr Dermatoonkologie des Deutschen Krebsforschungszentrums (DKFZ) Heidelberg, Mannheim, Doktorandin, Klinik f\u00fcr Dermatologie, Venerologie und Allergologie und Exzellenzzentrum Dermatologie Mannheim des Landes Baden-W\u00fcrttemberg, Universit\u00e4tsmedizin Mannheim, Ruprecht-Karls-Universit\u00e4t Heidelberg, Mannheim, Studentin der Humanmedizin und wissenschaftliche Hilfskraft, Medizinische Fakult\u00e4t Mannheim, Ruprecht-Karls-Universit\u00e4t Heidelberg, Mannheim. <b>V.\u00a0M\u00fcller<\/b>: A.\u00a0Finanzielle Interessen: Referentenhonorar oder Kostenerstattung als passiver Teilnehmer: AbbVie, Janssen-Cilag, Merck Sharp and Dohme, Novartis, Pierre Fabre, Sanofi.\u00a0\u2013 Bezahlter Berater\/interner Schulungsreferent\/Gehaltsempf\u00e4nger o.\u202f\u00c4.: Pierre Fabre, Roche.\u00a0\u2013 Aktien: Biontech, CureVac.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Fach\u00e4rztin f\u00fcr Dermatologie, Funktionsober\u00e4rztin, Universit\u00e4tsmedizin Mannheim | Mitgliedschaften: DDG, ADO, DGDC.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}